Literature DB >> 11181521

Limited redundancy of survival signals from the type 1 insulin-like growth factor receptor.

M Navarro1, R Baserga.   

Abstract

The type 1 insulin-like growth factor receptor (IGF-IR) is effective in protecting cells from a variety of apoptotic injuries. In 32D murine hemopoietic cells, the IGF-IR sends three separate survival signals, through insulin receptor substrate-1, Shc, and mitochondrial Raf translocation. We report here that these three pathways for survival have a limited redundancy. If one of these pathways is blocked, the IGF-IR can still protect 32D cells from apoptosis induced by interleukin-3 withdrawal. However, when two of the three pathways are inactivated, the receptor is no longer capable to protect cells from apoptosis. The survival signal can use any two pathway combinations.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11181521     DOI: 10.1210/endo.142.3.7991

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  14 in total

1.  Regulation of Id gene expression by type I insulin-like growth factor: roles of Stat3 and the tyrosine 950 residue of the receptor.

Authors:  M Prisco; F Peruzzi; B Belletti; R Baserga
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

2.  Effect of blocking IGF-I receptor on growth of human hepatocellular carcinoma cells.

Authors:  You-Cheng Zhang; Xiao-Peng Wang; Ling-Yi Zhang; Ai-Lin Song; Zhi-Min Kou; Xu-Sheng Li
Journal:  World J Gastroenterol       Date:  2006-07-07       Impact factor: 5.742

Review 3.  IGF-I receptor signalling in transformation and differentiation.

Authors:  B Valentinis; R Baserga
Journal:  Mol Pathol       Date:  2001-06

4.  Rituximab (Rituxan) therapy for severe thyroid-associated ophthalmopathy diminishes IGF-1R(+) T cells.

Authors:  Allison N McCoy; Denise S Kim; Erin F Gillespie; Stephen J Atkins; Terry J Smith; Raymond S Douglas
Journal:  J Clin Endocrinol Metab       Date:  2014-03-26       Impact factor: 5.958

Review 5.  Role of insulin-like growth factor-1 (IGF-1) pathway in the pathogenesis of Graves' orbitopathy.

Authors:  Terry J Smith; Laszlo Hegedüs; Raymond S Douglas
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2012-06       Impact factor: 4.690

Review 6.  Caveolin-1 and polymerase I and transcript release factor: new players in insulin-like growth factor-I receptor signaling.

Authors:  M Hamoudane; S Maffioli; R Cordera; D Maggi; B Salani
Journal:  J Endocrinol Invest       Date:  2013-02-12       Impact factor: 4.256

7.  B cells from patients with Graves' disease aberrantly express the IGF-1 receptor: implications for disease pathogenesis.

Authors:  Raymond S Douglas; Vibharavi Naik; Catherine J Hwang; Nikoo F Afifiyan; Andrew G Gianoukakis; Daniel Sand; Shweta Kamat; Terry J Smith
Journal:  J Immunol       Date:  2008-10-15       Impact factor: 5.422

8.  Role of pescadillo and upstream binding factor in the proliferation and differentiation of murine myeloid cells.

Authors:  Marco Prisco; Arianna Maiorana; Clara Guerzoni; George Calin; Bruno Calabretta; Renate Voit; Ingrid Grummt; Renato Baserga
Journal:  Mol Cell Biol       Date:  2004-06       Impact factor: 4.272

9.  Polycystic Ovary Syndrome and the Forgotten Uterus.

Authors:  Pardis Hosseinzadeh; Maya Barsky; William E Gibbons; Chellakkan S Blesson
Journal:  F S Rev       Date:  2020-12-13

10.  Multiple antitumor effects of picropodophyllin in colon carcinoma cell lines: clinical implications.

Authors:  Xiaoying Feng; Eiman Aleem; Yingbo Lin; Magnus Axelson; Olle Larsson; Thomas Strömberg
Journal:  Int J Oncol       Date:  2011-12-06       Impact factor: 5.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.